Synapse - Works

Results (5712)

Health-related quality-of-life (HRQoL) analysis from the phase 3 CLEAR trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) or everolimus (EVE) versus sunitinib (SUN) for patients (pts) with advanced renal cell carcinoma (aRCC)

Meeting Abstract

Motzer, R. J.; Porta, C.; Alekseev, B.; Rha, S. Y.; Choueiri, T. K.; Mendez-Vidal, M. J.; Hong, S. H.; Kapoor, A.; Goh, J. C.; Eto, M.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

A prospective phase 2/3 study of PSMA-targeted (18)F-DCFPyL-PET/CT in patients (pts) with prostate cancer (PCa) (OSPREY): A sub-analysis of disease staging changes in PCa pts with recurrence or metastases on conventional imaging

Meeting Abstract

Durack, J. C.; Alva, A. S.; Preston, M. A.; Pouliot, F.; Saperstein, L.; Carroll, P. R.; Pienta, K. J.; Rowe, S. P.; Patnaik, A.; Probst, S.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Overall survival and exploratory subgroup analyses from the phase 2 CodeBreaK 100 trial evaluating sotorasib in pretreated KRAS p.G12C mutated non-small cell lung cancer

Meeting Abstract

Skoulidis, F.; Li, B. T.; Govindan, R.; Dy, G. K.; Shapiro, G.; Bauml, J.; Schuler, M. H.; Addeo, A.; Kato, T.; Besse, B.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Efficacy and safety of larotrectinib in adult and pediatric patients with tropomyosin receptor kinase (TRK) fusion-positive primary central nervous system tumors

Meeting Abstract

Perreault, S.; van Tilburg, C. M.; Geoerger, B.; Nysom, K.; Ora, I.; Gavrilovic, I. T.; Norenberg, R.; Dima, L.; De La Cuesta, E. A.; Drilon, A. E.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Phase 1 expansion trial of the LSD1 inhibitor seclidemstat (SP-2577) with and without topotecan and cyclophosphamide (TC) in patients (pts) with relapsed or refractory Ewing sarcoma (ES) and select sarcomas

Meeting Abstract

Reed, D. R.; Chawla, S. P.; Setty, B.; Mascarenhas, L.; Meyers, P. A.; Metts, J.; Harrison, D. J.; Lessnick, S. L.; Crompton, B. D.; Loeb, D.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Phase (Ph) 1b/2 evaluation of olaratumab in combination with gemcitabine and docetaxel in advanced soft tissue sarcoma (STS)

Meeting Abstract

Attia, S.; Villalobos, V. M.; Hindi, N.; Van Tine, B. A.; Wagner, A. J.; Chmielowski, B.; Levy, D. E.; Ceccarelli, M.; Jones, R. L.; Dickson, M. A.
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Safety and efficacy of rogaratinib in combination with atezolizumab in cisplatin-ineligible patients (pts) with locally advanced or metastatic urothelial cancer (UC) and FGFR mRNA overexpression in the phase Ib/II FORT-2 study

Meeting Abstract

Rosenberg, J. E.; Gajate, P.; Morales-Barrera, R.; Lee, J. L.; Necchi, A.; Penel, N.; Zagonel, V.; Sierecki, M. R.; Bao, W. C.; Zhou, Y. H.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

BREAKWATER: Randomized phase 3 study of encorafenib (enco) + cetuximab (cetux) ± chemotherapy for first-line (1L) treatment (tx) of BRAF V600E-mutant (BRAF(V600E)) metastatic colorectal cancer (mCRC)

Meeting Abstract

Kopetz, S.; Grothey, A.; Yaeger, R.; Ciardiello, F.; Desai, J.; Kim, T. W.; Maughan, T.; Van Cutsem, E.; Wasan, H. S.; Yoshino, T.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Global BRAF testing practices in metastatic colorectal cancer (mCRC)

Meeting Abstract

Desai, J.; Kopetz, S.; Grothey, A.; Ciardiello, F.; Kim, T. W.; Maughan, T.; Van Cutsem, E.; Wasan, H. S.; Yaeger, R.; Yoshino, T.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Outcomes of patients who progressed while receiving avelumab + axitinib (A + Ax) and received subsequent treatment (Tx) in JAVELIN Renal 101

Meeting Abstract

Albiges, L.; Voss, M. H.; Rini, B. I.; Gravis, G.; Grimm, M. O.; Nathan, P. D.; Bjarnason, G. A.; Tomita, Y.; Penkov, K.; McGregor, B.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save